1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one

C25H31N7O2 — CID 71455457

IUPAC1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one
SMILESCn1cnc(-c2cn([C@H]3C[C@@H](C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)c1
InChIInChI=1S/C25H31N7O2/c1-29-16-21(26-18-29)22-17-32(28-27-22)20-14-23(25(34)30-12-5-6-13-30)31(15-20)24(33)11-7-10-19-8-3-2-4-9-19/h2-4,8-9,16-18,20,23H,5-7,10-15H2,1H3/t20-,23-/m0/s1
InChIKeyWWOPESLGHGCKCM-REWPJTCUSA-N
MW461.57 g/mol
LogP2.47
Rot. Bonds7

About 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one

1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one (PubChem CID 71455457) has the molecular formula C25H31N7O2 and a molecular weight of 461.57 g/mol. Its IUPAC name is 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one.

Molecular Properties

Compound Name1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one
PubChem CID71455457
Molecular FormulaC25H31N7O2
Molecular Weight461.57 g/mol
Exact Mass461.25
IUPAC Name1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one
SMILESCn1cnc(-c2cn([C@H]3C[C@@H](C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)c1
InChIInChI=1S/C25H31N7O2/c1-29-16-21(26-18-29)22-17-32(28-27-22)20-14-23(25(34)30-12-5-6-13-30)31(15-20)24(33)11-7-10-19-8-3-2-4-9-19/h2-4,8-9,16-18,20,23H,5-7,10-15H2,1H3/t20-,23-/m0/s1
InChIKeyWWOPESLGHGCKCM-REWPJTCUSA-N
XLogP2.47
TPSA89.15 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500461.57
LogP ≤ 52.47
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one?
The IUPAC name of 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one (CID 71455457) is 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one.
What is the SMILES notation for 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one?
The canonical SMILES for 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one is Cn1cnc(-c2cn([C@H]3C[C@@H](C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)c1.
What is the InChIKey of 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one?
The InChIKey is WWOPESLGHGCKCM-REWPJTCUSA-N. The full InChI is InChI=1S/C25H31N7O2/c1-29-16-21(26-18-29)22-17-32(28-27-22)20-14-23(25(34)30-12-5-6-13-30)31(15-20)24(33)11-7-10-19-8-3-2-4-9-19/h2-4,8-9,16-18,20,23H,5-7,10-15H2,1H3/t20-,23-/m0/s1.
What are the key properties of 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one?
1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one has a molecular weight of 461.57 g/mol, XLogP of 2.47, 7 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2S,4S)-4-[4-(1-methylimidazol-4-yl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one is sourced from PubChem (CID 71455457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).